EPA and LY2606368 differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study. Website: https://www.selleckchem.com/products/Everolimus(RAD001).html